|
Jun 13
|
Bavarian Nordic launches chikungunya vaccine trial for paediatric population
|
|
Jun 12
|
Bavarian Nordic Initiates Phase 3 Study of Chikungunya Vaccine in Children
|
|
Apr 1
|
FDA approves Bavarian Nordic’s freeze-dried mpox and smallpox vaccine
|
|
Mar 31
|
Bavarian Nordic Receives U.S. FDA Approval of Freeze-Dried Smallpox and Mpox Vaccine
|
|
Feb 19
|
Undiscovered Gems And 2 Other Promising Small Caps With Strong Potential
|
|
Feb 17
|
Bavarian Nordic scoops FDA approval for chikungunya vaccine in adults and teens
|
|
Oct 3
|
Bavarian Nordic (BVNRY) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
|
|
Sep 27
|
UNICEF secures one million mpox vaccines for Africa
|
|
Sep 26
|
Bavarian Nordic Signs Agreement with UNICEF for 1 Million Mpox Vaccines
|
|
Sep 26
|
Bavarian Nordic Upgrades its Financial Guidance for 2024
|
|
Sep 25
|
Bavarian Nordic gains US contract for additional mpox vaccine
|
|
Sep 24
|
Bavarian Nordic Awarded USD 63 Million from the U.S. Government for Production and Supply of Additional Smallpox/Mpox Vaccines
|
|
Aug 27
|
Singapore approves mpox vaccine as it adds border infection checks
|
|
Aug 27
|
Bavarian Nordic Receives Approval of Smallpox and Mpox Vaccine in Singapore
|
|
Jul 26
|
Bavarian Nordic wins positive CHMP opinion to amend Imvanex approval
|
|
Jul 26
|
Bavarian Nordic Receives Positive CHMP Opinion for Including Mpox Real-world Effectiveness Data in European Marketing Authorization for Smallpox and Mpox Vaccine
|
|
Jun 17
|
Bavarian Nordic Completes BLA Submission to U.S. FDA for its Chikungunya Vaccine Candidate
|
|
May 8
|
Bavarian Nordic Launches Share Buy-Back Program to Hedge Incentive Scheme Obligations
|
|
May 8
|
Bavarian Nordic Announces Interim Results for the First Three Months of 2024
|
|
Mar 21
|
Bavarian Nordic A/S – Notice Convening Annual General Meeting
|